Recent Analyst Forecasts and Stock Ratings
BridgeBio Oncology Therapeutics Inc. FAQ's
BridgeBio Oncology Therapeutics Inc. has been rated by research analysts at Canaccord Genuity, Stifel Nicolaus, Raymond James, Morgan Stanley, Leerink Partners, H.C. Wainwright in the past 90 days.